Results 201 to 210 of about 816,685 (307)

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

open access: yesMolecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin   +10 more
wiley   +1 more source

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding. [PDF]

open access: yesOncotarget, 2018
van Brummelen EMJ   +14 more
europepmc   +1 more source

IMMUNOGENIC EPITOPES OF THE p55 CHAIN OF THE IL-2 RECEPTOR RELATIONSHIPS TO HIGH-AFFINITY IL-2 BINDING AND MODULATION OF THE P55 CHAIN

open access: bronze, 1990
Johnson T. Wong   +4 more
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis. [PDF]

open access: yesCancer Immunol Immunother, 2017
Neitzke DJ   +9 more
europepmc   +1 more source

Peripheral blood hairy cell leukemia cells express only low affinity IL-2 receptors

open access: hybrid, 1994
Kyran Bulger   +4 more
openalex   +1 more source

Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway [PDF]

open access: gold, 1998
Tsuyoshi Miyazaki   +9 more
openalex   +1 more source

A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla   +15 more
wiley   +1 more source

PHA induces IL-2 receptors on B-CLL cells and is a potential biological response modifier for the LIL-2-diphtheria toxin, DAB486IL-2

open access: hybrid, 1994
Kyran Bulger   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy